HURN Q2 2026 Results: Record Revenue, Guidance Raise Reinforce Buy Thesis

What happened

Huron delivered record second-quarter 2026 revenues before reimbursable expenses (RBR), rising 16% year-over-year on broad-based organic growth across all three segments. This performance marks an acceleration from the trends noted in the master report and was accompanied by an increase in full-year 2026 guidance. The results validate the thesis that Huron's vertical specialization in healthcare, education, and commercial markets, combined with expanding digital and managed services, is driving durable demand and margin expansion. The successful integration of recent acquisitions such as AXIA, Eclipse Insights, and TVG‑Treliant is already contributing to this outperformance. Management's execution reinforces our view that Huron is well-positioned to sustain above-market growth and profitability improvements.

Implication

Investors should view the record results and guidance raise as a clear sign that Huron’s strategy is paying off, with accelerating organic growth and margin enhancement likely to drive earnings beats ahead. The company's growing mix of higher-margin managed and digital services should provide valuation support relative to consulting peers. While integration risks from the acquisition spree bear watching, the pace of synergy realization appears ahead of schedule. We recommend using any dips to add to positions, as the market may still be underestimating the durability of this growth story. Overall, the risk/reward profile has improved, and we see potential for the stock to re-rate toward the high end of its peer group.

Thesis delta

No shift—the BUY thesis is reinforced. Record Q2 2026 results and raised guidance confirm robust organic growth and margin expansion, exactly as our thesis predicted. The integration of acquisitions is yielding tangible top-line benefits ahead of expectations, bolstering our conviction in the stock’s upside.